Flying L Partners logo

Flying L Partners

North America, Colorado, United States, Steamboat Springs

Description

Flying L Partners is an investment firm that focuses on investing in healthcare industry.

Investor Profile

Flying L Partners has made 6 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series B (67%)
  • Series Unknown (17%)
  • Series A (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Medical Device
  • Pharmaceutical
  • Health Diagnostics
  • Innovation Management
  • Wellness
  • Medical
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Flying L Partners frequently co-invest with?

Alcon
Europe, Geneve, Switzerland, Vernier
Co-Investments: 1
PH
North America, New York, United States, New York
Co-Investments: 2
Horowitz Group
North America, California, United States, Newport Beach
Co-Investments: 1
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 1
Deerfield
North America, New York, United States, New York
Co-Investments: 1
Bluestem Capital
North America, South Dakota, United States, Sioux Falls
Co-Investments: 1
FV
North America, California, United States, Menlo Park
Co-Investments: 2
Aperture Venture Partners
North America, New York, United States, New York
Co-Investments: 1
Visionary Venture Fund
North America, California, United States, Aliso Viejo
Co-Investments: 4
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1

What are some of recent deals done by Flying L Partners?

Aurion Biotechnologies

Seattle, Washington, United States

Aurion Biotechnologies is a clinical-stage biotech company.

BiopharmaBiotechnologyHealth CareMedical
Series UnknownApr 12, 2022
Amount Raised: $120,000,000
TearClear

Boston, Massachusetts, United States

TearClear is a pharmaceutical company that specializes in providing a disruptive eye health technology.

Chemical EngineeringMedical DevicePharmaceutical
Series BAug 11, 2020
Amount Raised: $22,000,000
Tarsus Pharmaceuticals

Irvine, California, United States

Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.

BiopharmaBiotechnologyLife Science
Series BJan 8, 2020
Amount Raised: $60,000,000
CorneaGen

Seattle, Washington, United States

CorneaGen innovates cornea care, from new medical devices and biologics to therapeutics and interventions.

BiotechnologyHealth CareHealth DiagnosticsInnovation ManagementMedical DeviceWellness
Series BJul 10, 2019
Amount Raised: $37,000,000
Oyster Point Pharmaceuticals

San Francisco, California, United States

Oyster is a clinical stage pharmaceutical company focused on the discovery development & commercialization .

BiopharmaClinical TrialsHealth CareMedicalPharmaceutical
Series BFeb 26, 2019
Amount Raised: $93,000,000
CorneaGen

Seattle, Washington, United States

CorneaGen innovates cornea care, from new medical devices and biologics to therapeutics and interventions.

BiotechnologyHealth CareHealth DiagnosticsInnovation ManagementMedical DeviceWellness
Series AOct 18, 2016
Amount Raised: $10,000,000